Related Experiment Video

Updated: Jun 18, 2025

Adenoviral Gene Therapy for Diabetic Keratopathy: Effects on Wound Healing and Stem Cell Marker Expression in Human Organ-cultured Corneas and Limbal Epithelial Cells
11:13

Adenoviral Gene Therapy for Diabetic Keratopathy: Effects on Wound Healing and Stem Cell Marker Expression in Human Organ-cultured Corneas and Limbal Epithelial Cells

Published on: April 7, 2016

9.1K

Correction: Limited potential of AAV-mediated gene therapy in transducing human mesenchymal stem cells for bone

Sofia Bougioukli1, Morgan Chateau2, Heidy Morales2

  • 1Department of Orthopaedic Surgery, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA. sofiabougioukli26@gmail.com.

Gene Therapy
|August 1, 2024
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Author Spotlight: Advancements in iPSCs and Genetic Disease Research
06:24

Author Spotlight: Advancements in iPSCs and Genetic Disease Research

Published on: October 20, 2023

1.1K
Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells
11:16

Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells

Published on: February 15, 2019

7.6K

Related Experiment Videos

Last Updated: Jun 18, 2025

Adenoviral Gene Therapy for Diabetic Keratopathy: Effects on Wound Healing and Stem Cell Marker Expression in Human Organ-cultured Corneas and Limbal Epithelial Cells
11:13

Adenoviral Gene Therapy for Diabetic Keratopathy: Effects on Wound Healing and Stem Cell Marker Expression in Human Organ-cultured Corneas and Limbal Epithelial Cells

Published on: April 7, 2016

9.1K
Author Spotlight: Advancements in iPSCs and Genetic Disease Research
06:24

Author Spotlight: Advancements in iPSCs and Genetic Disease Research

Published on: October 20, 2023

1.1K
Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells
11:16

Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells

Published on: February 15, 2019

7.6K

Related Concept Videos

Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

4.7K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.7K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K

Articles linked to this work by shared authors, journal, and citation graph.

Standardized Letters of Recommendation and Match Success Among Orthopaedic Surgery Residency Applicants.

Journal of graduate medical education·2026

Practice Management Strategies Among the Current Members of the American Association of Hip and Knee Surgeons.

The Journal of arthroplasty·2026

Cirrhosis is associated with an increased risk of periprosthetic joint infection following total joint arthroplasty.

Journal of clinical orthopaedics and trauma·2026

Sobering Outcomes After Two-Stage Revision for Periprosthetic Joint Infection Among Patients Who Have Revision Total Knee Arthroplasty Components.

The Journal of arthroplasty·2026

Increased Polymicrobial Infection Rates and Associated Mortality in Patients With Chronic Gastrointestinal Disease Undergoing Antibiotic Spacer Placement for Periprosthetic Joint Infection.

Arthroplasty today·2026

Quantifying the Age-Dependent Risk of Periprosthetic Femoral Fracture Following Cementless Total Hip Arthroplasty: An Analysis Using Age as a Continuous Variable.

The Journal of arthroplasty·2026

Prevalence of adeno-associated virus type 3B neutralizing antibodies in cohorts of healthy donors and Wilson's disease adults.

Gene therapy·2026

Chronic lung infection does not impair lentiviral vector gene transfer in a cystic fibrosis rat model.

Gene therapy·2026

Statistical correlation between strength and mini-dystrophin expression in skeletal muscle after an rAAV9-mini-dystrophin gene therapy candidate in DMDmdx rats.

Gene therapy·2026

Local targeted suppression of neocortical spreading depolarization amplitude by viral expression of KCa3.1 channels.

Gene therapy·2026

Rational selection of SpCas9 and variant-derived adenine base editors for human genome editing.

Gene therapy·2026

Patient, consumer and societal values, perceptions and preferences on high-cost gene therapies.

Gene therapy·2026

Menin inhibition with revumenib clears measurable residual disease in acute myeloid leukemia with UBTF tandem duplication after allogeneic stem cell transplantation.

Haematologica·2026

Navigating the landscape of stem cell therapeutics: Overcoming translational hurdles via emerging technologies and regulatory frontiers.

Pharmacology & therapeutics·2026

Immunosuppressive termination of pro-inflammatory miRNA degradation via circular RNA nanosponge for sepsis-induced cardiomyopathy treatment.

Journal of controlled release : official journal of the Controlled Release Society·2026

Resiquimod Improves the Tumor Accumulation and Antitumor Activity of SN38 Prodrug-Loaded Liposomes.

Molecular pharmaceutics·2026

Stem Cell and EV/sEV Strategies for Neuroimmune Niche Reprogramming in Selected CNS Disorders: Mechanisms, Engineered Delivery, and Translational Readiness.

CNS neuroscience & therapeutics·2026

A comparison of overall survival and quality of life in patients with MDS treated with azacytidine vs decitabine.

Blood neoplasia·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us